PMC:7205724 / 1352-1486 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"60","span":{"begin":91,"end":99},"obj":"Species"},{"id":"64","span":{"begin":115,"end":126},"obj":"Chemical"},{"id":"75","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"76","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"Tax:9606"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:C502936"},{"id":"A75","pred":"tao:has_database_id","subj":"75","obj":"MESH:C000657245"},{"id":"A76","pred":"tao:has_database_id","subj":"76","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":2,"end":10},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"T17","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":128,"end":129},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T3","span":{"begin":62,"end":72},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A3","pred":"meddra_id","subj":"T3","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062178"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T16","span":{"begin":14,"end":22},"obj":"Species"},{"id":"T17","span":{"begin":105,"end":113},"obj":"Species"}],"attributes":[{"id":"A16","pred":"ncbi_taxonomy_id","subj":"T16","obj":"NCBItxid:2697049"},{"id":"A17","pred":"ncbi_taxonomy_id","subj":"T17","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"75","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"60","span":{"begin":91,"end":99},"obj":"Species"},{"id":"76","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"64","span":{"begin":115,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A75","pred":"pubann:denotes","subj":"75","obj":"MESH:C000657245"},{"id":"A60","pred":"pubann:denotes","subj":"60","obj":"Tax:9606"},{"id":"A76","pred":"pubann:denotes","subj":"76","obj":"MESH:C000657245"},{"id":"A64","pred":"pubann:denotes","subj":"64","obj":"MESH:C502936"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T204","span":{"begin":2,"end":10},"obj":"NN"},{"id":"T205","span":{"begin":11,"end":13},"obj":"IN"},{"id":"T206","span":{"begin":14,"end":22},"obj":"NN"},{"id":"T207","span":{"begin":23,"end":33},"obj":"VBD"},{"id":"T208","span":{"begin":34,"end":38},"obj":"IN"},{"id":"T209","span":{"begin":39,"end":47},"obj":"NN"},{"id":"T210","span":{"begin":47,"end":48},"obj":"-COMMA-"},{"id":"T211","span":{"begin":49,"end":60},"obj":"NN"},{"id":"T212","span":{"begin":60,"end":61},"obj":"-COMMA-"},{"id":"T213","span":{"begin":62,"end":67},"obj":"JJ"},{"id":"T214","span":{"begin":68,"end":72},"obj":"NN"},{"id":"T215","span":{"begin":72,"end":73},"obj":"-COMMA-"},{"id":"T216","span":{"begin":74,"end":77},"obj":"CC"},{"id":"T217","span":{"begin":78,"end":87},"obj":"NN"},{"id":"T218","span":{"begin":88,"end":90},"obj":"IN"},{"id":"T219","span":{"begin":91,"end":99},"obj":"NNS"},{"id":"T220","span":{"begin":100,"end":104},"obj":"IN"},{"id":"T221","span":{"begin":105,"end":113},"obj":"NN"},{"id":"T222","span":{"begin":115,"end":126},"obj":"NNP"},{"id":"T223","span":{"begin":126,"end":127},"obj":"-COMMA-"},{"id":"T224","span":{"begin":128,"end":129},"obj":"DT"}],"relations":[{"id":"R196","pred":"arg1Of","subj":"T204","obj":"T205"},{"id":"R197","pred":"arg2Of","subj":"T216","obj":"T205"},{"id":"R198","pred":"arg2Of","subj":"T206","obj":"T207"},{"id":"R199","pred":"arg1Of","subj":"T207","obj":"T208"},{"id":"R200","pred":"arg2Of","subj":"T209","obj":"T208"},{"id":"R201","pred":"arg1Of","subj":"T209","obj":"T210"},{"id":"R202","pred":"arg2Of","subj":"T211","obj":"T210"},{"id":"R203","pred":"arg1Of","subj":"T206","obj":"T212"},{"id":"R204","pred":"arg2Of","subj":"T214","obj":"T212"},{"id":"R205","pred":"arg1Of","subj":"T214","obj":"T213"},{"id":"R206","pred":"arg1Of","subj":"T216","obj":"T215"},{"id":"R207","pred":"arg1Of","subj":"T212","obj":"T216"},{"id":"R208","pred":"arg2Of","subj":"T217","obj":"T216"},{"id":"R209","pred":"arg1Of","subj":"T217","obj":"T218"},{"id":"R210","pred":"arg2Of","subj":"T219","obj":"T218"},{"id":"R211","pred":"arg1Of","subj":"T219","obj":"T220"},{"id":"R212","pred":"arg2Of","subj":"T221","obj":"T220"},{"id":"R213","pred":"arg1Of","subj":"T222","obj":"T223"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T4","span":{"begin":2,"end":10},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T16","span":{"begin":14,"end":22},"obj":"Disease"},{"id":"T17","span":{"begin":105,"end":113},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"d cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19. Tocilizumab, a mono"}